As of June 30, the Company had cash and cash equivalents of approximately $47.8 M As of August 7 the Company had approximately 18.0 million common shares outstanding.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on INMB:
- INmune Bio Inc. Announces Second Quarter 2023 Results and Provides Business Update
- INmune Bio, Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on Monday, August 7
- INMB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- INmune Bio announces novel MRI biomarker data to be presented at AAIC
- INmune Bio Inc. Announces Novel MRI Biomarker Data Demonstrating Improvement in Gray Matter in Patients with Alzheimer’s Disease